Rebel's Edge with Jon & Pete Najarian

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Alaska Airlines spiking on strong guidance, eBay making Morgan Stanley analysts swoon with their AI adoption, Lithium Americas Corp making moves with GM, and D.R. Horton with a big beat. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including United Airlines beating estimates, Vanda Pharmaceutical fielding a buyout offer, J.B. Hunt missing on earnings, and ASML with a big miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about paying O...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Apple losing the top smartphone spot to Samsung, Live Nation facing an antitrust lawsuit, Morgan Stanley posting a good quarter, and Intra-Cellular Therapies seeing encouraging phase 3 results. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospect...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Goldman Sach's surging profits, Encore Wire getting bought out, Medical Properties Trust unloading some hospitals, and Neumora Therapeutics having a phase 1 trial halted by the FDA. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and marke...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Delta Airlines beating on earnings, Hexcel surprising Wall Street with a new CEO announcement, Google announcing a new ARM-based CPU to bolster its AI game, and the Consumer Discretionary reaction to inflation. dipping after a dismal earnings report. Gain a deeper understanding of these stocks as Jon and...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including UOA in gold related stocks, Alkermes making progress with a narcolepsy treatment, Borr Drilling booking out use of their jack-up rigs, and Neogen Corp. dipping after a dismal earnings report. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects,...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Coinbase, Apartment Income REIT, Perion Networks, and Ducommun. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about South Carolina women's basketball and The Bears. Stay on the cutting edge with Reb...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Dave & Buster's spiking 12%, Intel facing $7B in losses, e.l.f. Beauty featured in Tik Tok Shop Super Brand Day, and Signet Jewelers enjoying a bump. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk ab...

Join Jon Najarian and special guest Marc LoPresti on today's episode of Rebel's Edge as they discuss stocks including Humana falling on bad Medicare news, Verve Therapeutics having trouble with a phase 1 trial, PVH falling in spite of strong earnings, and what to make of the GE spin-off. Gain a deeper understanding of these stocks as Jon and Marc share their perspectives, potential growth prospect...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Cameco Corp enjoying a favorable uranium market, Advent International's plans to takeover Nuvei, Disc Medicine reporting a placebo problem, and CleanSpark's stellar year. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictio...

Join Pete Najarian and special guest, Marc LoPresti, on today's episode of Rebel's Edge as they discuss stocks including Marc's prediction that the real place to make AI money in 2024 is B2B, as embodied by promising SaaS player, Verint. They also cover Renovation Hardware, Sprinklr and, Miller Knoll. Gain a deeper understanding of these stocks as Marc and Pete share their perspectives, potential...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including the FDA approving a new Merck treatment, Robinhood offering a credit card, nCino spiking on strong guidance, and GameStop tanking on a huge miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Krispy Kreme partnering with McDonald's, Reddit's $11 Billion post-IPO valuation, Viking Therapeutics spiking again based on their promising oral weight loss treatment, and Trump Media's record breaking SPAC. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Boeing ditching their CEO and Chairman of the Board, Intel and AMD taking a hit on new restrictions from China, Apple facing antitrust allegations from the DoJ, and Masimo announcing that it will spin off it's consumer business. Gain a deeper understanding of these stocks as Jon and Pete share their pers...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Immunovant showing signs of being oversold, AI hardware player, Micron, spiking after UOA, Lufax making a splash in the Chinese wealth management space, and FiveBelow crying "shrinkage." Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Signet Jewelers losing its luster, Pinduoduo spiking on strong 4th quarter results, Chipotle announcing a 50-for-1 stock split, and a NASDAQ shareholder shakeup. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. Stay...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including short interest in Paramount Global and Whirlpool, a chance to buy the dip on news of Super Micro Computer's equity offering, a huge UOA player who had advanced knowledge of AstraZeneca's buyout of Fusion Pharmaceuticals, and Nordstrom's founding family taking a shot at a takeover. Gain a deeper understan...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including XPeng planning a low-cost EV brand, B. Riley Financial shockingly missing its deadline to file an audited annual report, Apple announcing plans to license Google's Gemini AI for use on iPhones, and HCP considering a sale. Gain a deeper understanding of these stocks as Jon and Pete share their perspective...

Join Pete Najarian and special guest, Marc LoPresti, on today's episode of Rebel's Edge as they discuss stocks including Robinhood riding the current bitcoin rally to 52-week highs, UiPath beating expectations, Citigroup rallying after a ton of UOA activity, and Hello Group falling 16%. Gain a deeper understanding of these stocks as Marc and Pete share their perspectives, potential growth prospect...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Williams-Sonoma moving up in spite of the rough housing market, Dollar Tree missing estimates so hard that they plan to close 1000 stores, HUTCHMED moving into profitability, and BeiGene making progress on a new Leukemia treatment. Gain a deeper understanding of these stocks as Jon and Pete share their p...

Join Pete Najarian and special guest, Marc LoPresti, on today's episode of Rebel's Edge as they discuss stocks including Oracle continuing to reap the benefits of the data wave, On Holdings taking a hit, Acadia Therapeutics abandoning trials for Pimavanserin, and Southwest Airlines dipping on news of revised guidance. Gain a deeper understanding of these stocks as Marc and Pete share their perspec...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Barclays maintaining $146 price target for Coinbase as it jumps past $266, Choice Hotels increasing its share repurchase to $6.8M, EQT Corp. buying back Equitrans Midstream, and Moderna rallying for some reason. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potenti...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including American Eagle beating estimates, Victoria's Secret missing estimates, Chemours recovering after exposing financial manipulation by three of its executives, and Jessica Alba's promising endeavor, The Honest Company. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, pot...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Crowdstrike rocketing to the upside, Foot Locker posting weak guidance Coinbase riding the bitcoin wave, and Nordstrom dipping on missed guidance. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about...

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Target surging in spite of mixed results, GitLab shares taking a dip on weak guidance, Albermarle tanking along side battery raw materials, and Apple's bad start to 2024. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictio...